Nephros Inc.
Organization details
- Legal name
- Nephros Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 3841 — Surgical & Medical Instruments & Apparatus
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- South Orange
- Headquarters state / province
- New Jersey
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- NEPH
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001196298
- EIN
- 13-3971809
Board of directors
-
Alisa Lask · DirectorSince 2023
-
Arthur H. Amron · DirectorSince 2023
-
Joseph Michael Harris · DirectorSince 2023
-
Lisa Marie Nettis · DirectorSince 2025
-
Oliver J. Spandow · DirectorSince 2023
-
Robert R. Banks Jr. · Director · President and CEOSince 2023
-
Tom Gwydir · DirectorSince 2023
Chief executives
Outstanding · grade A+
Out of 100, from shareholder return, dividends, growth and acquisitions.
Partial: only 20% of the scoring weight is on file.
- Revenue growth 20%
- 100
23.5% a year in revenue
20% of the scoring weight is on file. Figures cover December 2022 – December 2025.
Director election results
Annual meeting of June 16, 2025. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
98.6%
Board connections
2 of this board's directors also sit on 2 other boards. 1 is in the same sector.
-
CollPlant Biotechnologies Ltd Same sectorvia Alisa Lask
- via Arthur H. Amron
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 14, 2026 | Amron Holdings LLC Director | Other | +17,749 | — | — |
| Sep 14, 2026 | Wexford GP LLC 10% owner | Other | −3,355,111 | — | — |
| Sep 14, 2026 | Amron Holdings LLC Director | Other | +2,836 | — | — |
| Sep 14, 2026 | Wexford GP LLC 10% owner | Other | −22,710 | $3.95 | $89,705 |
| Sep 14, 2026 | Amron Holdings LLC Director | Other | +22,710 | $3.95 | $89,705 |
| Aug 18, 2026 | Joseph Jacobs 10% owner | Option exercise | +812 | $3.60 | $2,923 |
| Aug 12, 2026 | Arthur H. Amron Director | Grant or award | +2,418 | — | — |
| May 11, 2026 | Arthur H. Amron Director | Grant or award | +3,574 | — | — |
| Mar 23, 2026 | Robert R. Banks Jr. Officer (President and CEO) | Option exercise | +120,000 | $1.44 | $172,800 |
| Mar 23, 2026 | Judy Krandel Officer (Chief Financial Officer) | Option exercise | +68,861 | $1.71 | $117,752 |
| Mar 16, 2026 | Arthur H. Amron Director | Grant or award | +3,610 | — | — |
| Nov 10, 2025 | Lisa Marie Nettis Director | Grant or award | +1,622 | — | — |
| Nov 10, 2025 | Oliver J. Spandow Director | Grant or award | +8,036 | — | — |
| Nov 10, 2025 | Arthur H. Amron Director | Grant or award | +5,391 | — | — |
| Jan 1, 2025 | Arthur H. Amron Director | Grant or award | +22,418 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Nephros Inc.
Who is the CEO of Nephros Inc.?
Robert R. Banks Jr. has been Nephros Inc.'s President and CEO since May 2023.
How many directors are on Nephros Inc.'s board?
Nephros Inc.'s board has 7 directors: Alisa Lask, Arthur H. Amron, Joseph Michael Harris, Lisa Marie Nettis, Oliver J. Spandow, Robert R. Banks Jr. and Tom Gwydir.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="nephros-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.